SEC Form 4 · accession 0001543209-16-000003
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles A. Nicolette
Officer — Chief Scientific Officer
Period of report
Jan 8, 2016
Accepted (ET)
Jan 12, 2016 · 9:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2016 | A | 48,604 | $0.00 | A | 63,117 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,383 shares of Common Stock acquired pursuant to the 2014 Employee Stock Purchase Plan on September 4, 2015.